Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
22.5 EUR | -0.62% | -3.52% | +1.44% |
04-25 | Transcript : Azelis Group NV, Q1 2024 Sales/ Trading Statement Call, Apr 25, 2024 | |
04-18 | EQT Weighs Options for Belgian Chemical Distributor Azelis | MT |
Strengths
- The opinion of analysts covering the stock has improved over the past four months.
Weaknesses
- The company benefits from high valuations in earnings multiples.
- The company is not the most generous with respect to shareholders' compensation.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- Revenue estimates are regularly revised downwards for the current and coming years.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Diversified Industrial Goods Wholesale
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+1.44% | 5.9B | B | ||
+57.27% | 94B | A- | ||
+27.12% | 65.11B | B+ | ||
+6.60% | 41.71B | C | ||
+39.79% | 31.94B | B | ||
+30.15% | 30.4B | B | ||
+20.67% | 21.85B | B | ||
+15.91% | 17.71B | B+ | ||
-3.13% | 12.81B | C+ | ||
-25.80% | 5.69B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- AZE Stock
- Ratings Azelis Group NV